Brow Lift Slovenia
Brow Lift in Slovenia section, includes general infrmation about Brow Lift Procedure, Brow Lift Slovenia Local News, Brow Lift Slovenia Surgeon Locator and other Brow Lift related material.
Slovenia Brow Lift - The Procedure
With age the brows drop below the eye line and wrinkles appear on the forehead, those make us look angry, sad and tired all times. Brow lift is most popular among ages 40-60 and you can combine it with a facelift or eyelid surgery.
Using the classic technique, the surgeon cuts ear to ear through the scalp behind the hairline. This allows him to get access to the forehead, release the muscles, removes extra skin and lift the eyebrows to higher position. This method is modified for people with high forehead and retreat in the hairline. Then the cut is made in front of the hairline so that brow lift doesn't cause additional retreat.
In the endoscopic approach 3-5 small incisions made on the scalp from ear to ear behind the hairline. Then using special tool extra skin and tissue being removed from the forehead and sometimes attached to the scalp from the inside. With time the wrinkles disappear. Sometimes the surgeon inserts special hook through the endoscop which attaches the tissue to the desired location. The hooks melt with time and the forehead reshapes. In another technique smaller cut is made through the temple areas, the extra skin is removed as described. This approach used when the outer portion of the brows needs to be lift. The operation can be done using local anesthetics with deep sedation.
Slovenia Brow Lift - Risks
Every operation has its complications. This one includes damage to the forehead nerves that will result in inability to move the forehead or brows. Lost sensation, usually temporarily, around the scar. Hair loss in the scar margins and wider scar. Infection and bleeding. Endoscopic complications can force the surgeon to do the open surgery, which has longer recovery period.
Slovenia Brow Lift - After Surgery
After the surgery with classic approach there might be uncomfortable felling of ant crawling and pain around the scar. Those usually disappear with time and the pain can be managed with painkillers. It may be difficult to open the eyes due to eyelid swallowing. The endoscopic approach has less pain and alter sensation.
Slovenia Brow Lift - Healing
You can return to work 10-14 days after the surgery but the final results can be seen only after a few weeks. You must avoid vigorous activities that can elevate your blood pressure for a few weeks. Also avoid prolonged heat or sun exposure. Most marks of the surgery resolve after 3 weeks, minimal swallowing and small hemorrhages can be covered with make up.
Other Brow Lift Procedures
All Face Procedures
Brow Lift Slovenia (current)
Brow Lift Slovenia BOTOX® Cosmetic
Brow Lift Slovenia Ear Surgery
Brow Lift Slovenia Facelift
Brow Lift Slovenia Neck Lift
More Slovenia info...
Plastic Surgery News...
- This British qualitative study examined the causes of preventable drug-related admissions (PDRAs) to hospital using semi-structured interviews and medical record review. It involved 62 participants (18 patients, 8 informal carers, 17 GPs, 12 community pharmacists, 3 practice nurses and 4 other members of healthcare staff) who had been involved in events leading up to the patients’ hospital admissions in Nottingham. The following findings were reported:
• PDRAs are associated with problems at multiple stages in the medication use process, including prescribing, dispensing, administration, monitoring and help seeking.
• The main causes of these problems are communication failures (between patients and healthcare professionals and different groups of healthcare professionals) and knowledge gaps (about drugs and patients’ medical and medication histories).
• The causes of PDRAs are similar irrespective of whether the hospital admission is associated with a prescribing, monitoring or patient adherence problem.
The researchers conclude “causes of PDRAs are multifaceted and complex. Technical solutions to PDRAs will need to take account of this complexity and are unlikely to be sufficient on their own. Interventions targeting the human causes of PDRAs are also necessary.”
They suggest that if the NHS patient care record currently under development is implemented effectively, it could help to alleviate some of the communication problems seen in this study, by allowing prescribers rapid access to medication and medical histories when patients are transferred between primary and secondary care, as well as the results of monitoring. In addition, pharmacists in secondary care are recognised as an important patient safety resource, aided by easy access to medical records; something that community pharmacists do not have access to, which makes their role in patient safety more limited. Again, the NHS patient care record could provide them with access to medical and medication histories, which would act as a defence against PDRM. However it is recognised that community pharmacists are likely to need additional training to ensure they can use it effectively, and more work is needed to address the relationships between pharmacists and prescribers, to make it easier for pharmacists to question potential problems they find on prescriptions. In addition, patients need to be provided with adequate information to maximise their ability to manage their own medication safely and appropriately.
- The National Prescribing Centre has produced a “blog” discussing a recently published study which concluded that although more patients taking varenicline experienced an adverse drug reaction, the drug appears to improve success rates over those achieved with nicotine replacement therapy (NRT) as observed in patients in a tobacco dependence clinic (study published in Addiction 2008; 103: 146-154).
The blog discusses the results of this study together with the NICE technology appraisal of smoking cessation with varenicline, and the MHRA and EMEA safety update of varenicline causing suicidal thoughts and behaviour.
The blog concludes that “Healthcare professionals should follow current NICE and MHRA guidance. Varenicline is an option in smoking cessation, but its use should be avoided in patients with underlying mental illness.”